Author name: DrugChatter

There used to be a reliable playbook. You identified the twenty physicians who shaped prescribing behavior in a given therapeutic […]

Across DrugChatter, a clear pattern emerges: patients are increasingly comfortable with switching to generics—but far less confident that “generic =

Across thousands of patient-facing Q&A threads on DrugChatter, a consistent pattern emerges: adherence to common medications is often shaped less

A growing share of medication questions aren’t being asked in exam rooms. They’re being typed into search bars and forums

Across thousands of DrugChatter threads, a clear pattern emerges: patients are no longer just asking what a drug does—they’re increasingly

There’s a particular genre of drug question that keeps resurfacing: not the obvious “what dose should I take?” but the

Across DrugChatter’s growing library of patient questions, a clear theme emerges: people are constantly trying to “switch” something in their

The correlation had been hiding in plain sight for two years before anyone in pharmaceutical commercial analytics thought to look

From statins and biologics to OTC painkillers, patients are increasingly turning to peer Q&A platforms to resolve uncertainty around how

Patients are increasingly turning to online forums before their first dose—less for diagnosis, more for reassurance. The result is a

Somewhere right now, a patient is asking an AI chatbot whether their oncology drug causes liver failure. The chatbot is

In theory, digital health queries should track clinical reality: drug–drug interactions, dosing guidance, adverse effects, and regulatory questions. In practice,